Olena Popazova

Ms. Olena Popazova

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
IBIgor Belenichev
Igor Belenichev
OPOlena Popazova
Olena Popazova
NBNina Bukhtiyarova
Nina Bukhtiyarova
DSDmytro Savchenko
Dmytro Savchenko
Valentyn OksenychValentyn Oksenych
Valentyn Oksenych
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
Despite the significant progress in the fields of biology, physiology, molecular medicine, and pharmacology; the designation of the properties of nitrogen monoxide in the regulation of life-supporting functions of the organism; and numerous works devoted to this molecule, there are still many open questions in this field. It is widely accepted that nitric oxide (•NO) is a unique molecule that, despite its extremely simple structure, has a wide range of functions in the body, including the cardiovascular system, the central nervous system (CNS), reproduction, the endocrine system, respiration, digestion, etc. Here, we systematize the properties of •NO, contributing in conditions of physiological norms, as well as in various pathological processes, to the mechanisms of cytoprotection and cytodestruction. Current experimental and clinical studies are contradictory in describing the role of •NO in the pathogenesis of many diseases of the cardiovascular system and CNS. We describe the mechanisms of cytoprotective action of •NO associated with the regulation of the expression of antiapoptotic and chaperone proteins and the regulation of mitochondrial function. The most prominent mechanisms of cytodestruction—the initiation of nitrosative and oxidative stresses, the production of reactive oxygen and nitrogen species, and participation in apoptosis and mitosis. The role of •NO in the formation of endothelial and mitochondrial dysfunction is also considered. Moreover, we focus on the various ways of pharmacological modulation in the nitroxidergic system that allow for a decrease in the cytodestructive mechanisms of •NO and increase cytoprotective ones.

18 January 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
IBIgor Belenichev
Igor Belenichev
OPOlena Popazova
Olena Popazova
НБНина Бухтиярова
Нина Бухтиярова
Viсtor RyzhenkoViсtor Ryzhenko
Viсtor Ryzhenko
Sergii PavlovSergii Pavlov
Sergii Pavlov
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
The study of mitochondrial dysfunction has become increasingly pivotal in elucidating the pathophysiology of various cerebral pathologies, particularly neurodegenerative disorders. Mitochondria are essential for cellular energy metabolism, regulation of reactive oxygen species (ROS), calcium homeostasis, and the execution of apoptotic processes. Disruptions in mitochondrial function, driven by factors such as oxidative stress, excitotoxicity, and altered ion balance, lead to neuronal death and contribute to cognitive impairments in several brain diseases. Mitochondrial dysfunction can arise from genetic mutations, ischemic events, hypoxia, and other environmental factors. This article highlights the critical role of mitochondrial dysfunction in the progression of neurodegenerative diseases and discusses the need for targeted therapeutic strategies to attenuate cellular damage, restore mitochondrial function, and enhance neuroprotection.

21 October 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
OPOlena Popazova
Olena Popazova
IBIgor Belenichev
Igor Belenichev
НБНина Бухтиярова
Нина Бухтиярова
Viсtor RyzhenkoViсtor Ryzhenko
Viсtor Ryzhenko
Valentyn OksenychValentyn Oksenych
Valentyn Oksenych
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
Intrauterine hypoxia in newborns leads to a multifaceted array of alterations that exert a detrimental impact on the cardiovascular system. The aim of this research was to assess the cardioprotective effects of modulators of the nitric oxide (NO) system, including L-arginine, Thiotriazoline, Angiolin, and Mildronate, during the early postnatal period following intrauterine hypoxia. Methods: The study involved 50 female white rats. Pregnant female rats were given a daily intraperitoneal dose of 50 mg/kg of sodium nitrite starting on the 16th day of pregnancy. A control group of pregnant rats received saline instead. The resulting offspring were divided into the following groups: Group 1—intact rats; Group 2—rat pups subjected to prenatal hypoxia (PH) and daily treated with physiological saline; and Groups 3 to 6—rat pups exposed to prenatal hypoxia and treated daily from the 1st to the 30th day after birth. Nitrotyrosine levels, eNOS, iNOS, and NO metabolites were evaluated using ELISA; to measure the expression levels of iNOS mRNA and eNOS mRNA, a PCR test was utilized. Results: Angiolin enhances the expression of eNOS mRNA and boosts eNOS activity in the myocardium of rats with ischemic conditions. Arginine and particularly Thiotriazoline exhibited a consistent impact in restoring normal parameters of the cardiac nitroxidergic system following PH. Mildronate notably raised iNOS mRNA levels and notably reduced nitrotyrosine levels, providing further support for its antioxidative characteristics.

Verified
Journal Article
Open access
PDF file
OPOlena Popazova
Olena Popazova
IBIgor Belenichev
Igor Belenichev
OYOleh Yadlovskyi
Oleh Yadlovskyi
Valentyn OksenychValentyn Oksenych
Valentyn Oksenych
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
Many children and adults who have suffered prenatal hypoxia at an early age develop many serious diseases. This disease is an actual problem of pediatric cardiology and little studied. The aim was to analyze the cardioprotective effect of L-arginine, Thiotriazoline, Angioline, and Mildronate on the cardiovascular system of rats after prenatal hypoxia. Methods: The experiments were carried out on 50 female white rats; intraperitoneal sodium nitrite solution was administered daily to pregnant female rats after 16 days at a dose of 50 mg/kg. Control pregnant rats received saline. The offspring were divided into groups: 1—intact; 2—the control group of rat pups after PH, treated daily with physiological saline; 3—six groups of rat pups after PH, treated daily from the 1st to the 30th day after birth. Heat shock protein HSP70 was determined by enzyme immunoassay, ST2 Nitrotyrosine, and eNOS was observed by ELISA. Results: Angiolin showed a high cardioprotective effect even a month after discontinuation of the drug, and after introduction, the highest decrease in ST2 nitrotyrosine was revealed. Thiotriazoline and L-arginine have an antioxidant effect and a positive effect on eNOS expression, increasing the concentration of HSP70. Mildronate increased the expression of eNOS and the concentration of HSP70 in the blood of experimental rats after a course of administration, but did not show an antioxidant effect and did not reduce the concentration of nitrotyrosine. The results obtained indicate the cardioprotective effect of modulators of the NO system with different mechanisms of action of drugs after prenatal hypoxia.

8 September 2021 in Pharmacia
Verified
Journal Article
Open access
PDF file
BBBogdan S. Burlaka
Bogdan S. Burlaka
IBIgor F. Belenichev
Igor F. Belenichev
OROlga I. Ryzhenko
Olga I. Ryzhenko
VRVictor P. Ryzhenko
Victor P. Ryzhenko
OAOlena G. Aliyeva
Olena G. Aliyeva
PBPavlo G. Bak
Pavlo G. Bak
Introduction: This study was designed to evaluate the effect activity of RAIL-gel in comparison with Citicoline on nitroxydergic system during acute cerebrovascular accident. Methods: In this study, 80 white nonlinear rats were randomly assigned to 4 groups (20 rats in each): 1) intact; 2) control - untreated with acute cerebrovascular accident (ACVA), examined on the 4th day; 3) animals with ACVA, receiving RAIL, examined on the 18th day; 4) animals with ACVA, treated with Citicoline, examined on the 4th day. The expression of inducible NOS was determined by Western blotting. The nitrosative stress marker, nitrotyrosine, was determined using the ELISE kit NITROTYROSINE (kit no. HK501-02, series 12825k1212-k). To assess the state of iNOS mRNA expression, we used the method of polymerase chain reaction with reverse transcription in real time (RT-PCR). Results: Our research demonstrated that course administration of the RAIL and Citicoline to animals with ACVA for 4 days leads to the stabilization of the parameters of the brain nitroxydergic system. However, Citicoline does not provide a full effect on the shifts of the NO system in the brain. It does not have the proper effect on such an important link in the pathogenesis of ischemic brain damage as nitrosative stress. RAIL leads to a significant decrease in NOS activity due to its inducible form (decrease in the expression of iNOS and iNOS mRNA) and a decrease in NO metabolits, and inhibition of nitrosative stress (decrease in nitrotyrosine). Conclusion: IL-1b antagonist RAIL (Intranal Gel) significantly exceeds Citicoline in terms of the severity of the effect on the nitroxydergic system indicators.

1 December 2022 in Biopolymers and Cell
Verified
Journal Article
Open access
PDF file
IBI. F. Belenichev
I. F. Belenichev
PBP. G. Bak
P. G. Bak
OPOlena Popazova
Olena Popazova
NBN. V. Bukhtiyarova
N. V. Bukhtiyarova
OYO. E. Yadlovsky
O. E. Yadlovsky
Herein, we presented a review to show that the main mechanism underlying endothelial dysfunction is a decrease in the formation and bioavailability of NO against the background of inhibition of eNOS expression and reduced equivalents of the thiol-disulfide system with a simultaneous increase in the levels of cytotoxic forms of NO and the production of powerful vasoconstrictors. Based on the foregoing, the conjugated complex eNOS-L-arginine-NO/SH can be undoubtedly claimed in the near future as a promising target for the pharmacological correction of endothelial dysfunction. Since it is a nitrosative stress that plays the role in the development of endothelial dysfunction, it is topical to search for potential endothelial protectors in the series of S-substituted 1,2,4-triazole, which have the properties of antioxidanitts and NO scavengers. A striking representative of this cohort is Thiotriazolin which is a drug with cardioprotective, anti-ischemic and antioxidant properties, though does not possesses endothelial protective activity. As a result of chemical modification of the molecule of the latter, we obtained the compound (S)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate (Angiolin), which manifests endothelium-protective properties against the background of cardioprotective, anti-ischemic and antioxidant activities.